🇮🇳IN
Sign In
LA

LALPATHLAB

NSE

Dr. Lal Path Labs Ltd.

₹1,989.00

+25.80(+1.31%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector−₹5,497 Crnet foreign selling
2026-10-01 to 2026-10-15

This is the flow into the whole Healthcare sector, not into LALPATHLAB. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

LALPATHLAB exposure summary

Dr. Lal Path Labs Ltd. reports a single business segment, The business of running laboratories for carrying out Pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.. Dr. Lal Path Labs Ltd. is a constituent of 5 indices, with its largest weights in NIFTY Smallcap 100 (1.17%), S&P BSE 500 (0.08%), NIFTY 500 (0.07%). 12 exchange-traded funds hold the stock.

Index memberships5
ETFs holding12

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer